Teva Pharmaceutical Industries Limited (TEVA) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Teva Pharmaceutical Industries shareholders at a glance

The largest holder of Teva Pharmaceutical Industries stock is Harel Mutual Funds Ltd., with 72.3 million shares (6.21% of the company), worth about $2.58 billion as of September 25, 2026. The 10 largest holders together own 13.2%.

In Q2 2026, 724 institutional holdings reports listed 780.0 million shares worth $26.10 billion, up 15.4% in shares from Q1 2026.

Insiders reported 65 transactions in the last two years: 29 sales worth $70.25 million and 1 purchase. The newest one on file is from May 1, 2026 (Sabag Mark, Officer).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 1, 2026.

TEVA logo

Teva Pharmaceutical Industries Limited

TEVAIsrael
Healthcare

Shareholders Summary

2026Q2

Filings
724
Options Value
$965.00M
Value (excl. Options)
$26.10B
Shares (excl. Options)
780.00M

Ownership by Type

Geographic Distribution

Largest Teva Pharmaceutical Industries shareholders

HolderShares% of companyValue
Harel Mutual Funds Ltd.72.3 million6.21%$2.6B
Menora Mivtachim Holdings Ltd.49.9 million4.28%$1.8B
KSM Mutual Funds Ltd.12.2 million1.05%$438.0M
Migdal Mutual Funds Ltd.6.9 million0.59%$246.0M
IBI Mutual Funds Management (1978) Ltd.3.2 million0.28%$115.0M
Psagot Mutual Funds Ltd.2.5 million0.21%$90.0M
Phoenix Financial Ltd.2.2 million0.19%$78.0M
Amir Elstein0.1818 %2.1 million0.18%$76.0M
Ayalon Mutual Funds Ltd.1.6 million0.14%$59.0M
Richard Francis0.101 %1.2 million0.10%$42.0M

As of September 25, 2026.

Teva Pharmaceutical Industries institutional holdings by quarter

QuarterReportsSharesValue
Q2 2026724780.0 million$26.1B
Q1 2026701676.0 million$20.2B
Q4 2025714690.0 million$21.5B
Q3 2025628731.0 million$14.8B
Q2 2025606754.0 million$12.5B
Q1 2025619714.0 million$11.0B
Q4 2024646666.0 million$14.6B
Q3 2024599638.0 million$11.3B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Teva Pharmaceutical Industries insider trades

InsiderDateTitleTransactionValue
Sabag MarkMay 1, 2026OfficerSale at price 34.99 per share.$5.0M
Fox ChristineApr 30, 2026OfficerSale at price 35.31 per share.$750,620
Sabag MarkMar 5, 2026Officer--–
Kalif Eliyahu SharonMar 5, 2026Chief Financial Officer--–
Hughes Eric AMar 5, 2026Officer--–
Fox ChristineMar 5, 2026Officer--–
Shields MatthewMar 5, 2026Officer--–
Savage BrianMar 5, 2026Officer--–
Francis Richard DMar 5, 2026Chief Executive Officer--–
Francis Richard DMar 5, 2026Chief Executive OfficerSale at price 31.67 per share.$634,160
Hughes Eric AMar 5, 2026OfficerSale at price 31.67 per share.$301,895
Fox ChristineMar 5, 2026OfficerSale at price 31.67 per share.$250,940

Newest 12 of 65 insider transactions in the last two years.

Questions and answers

Who owns the most Teva Pharmaceutical Industries stock?

Harel Mutual Funds Ltd., with 6.21% of the company (as of September 25, 2026). Next: Menora Mivtachim Holdings Ltd. (4.28%) and KSM Mutual Funds Ltd. (1.05%).

How many institutions own Teva Pharmaceutical Industries stock?

724 institutional holdings reports listed Teva Pharmaceutical Industries shares in Q2 2026, 780.0 million shares in all worth $26.10 billion.

Are Teva Pharmaceutical Industries insiders buying or selling the stock?

In the last two years insiders reported 29 sales and 1 purchase (65 transactions in all); the newest on file is from May 1, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube